Vitality Biopharma, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (51)

Latest Posts

About This Stock More About This Stock
Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week
Article By: Lorimer Wilson
Sunday, April 25, 2021 3:00 AM EDT
Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC.
In this article: GWPH, ZYNE, CRBP, VBIO, RVVTF, CNBX, TBPMF, IMLFF, MGCLF, ZLDAF, ARTL, ENVB
Read
Interview With Vitality Biopharma Inc.
Article By: InvestInMJ
Monday, January 30, 2017 3:00 PM EDT
We recently had the pleasure to speak to Robert Brooke, the CEO of Vitality Biopharma, a publicly traded pharmaceutical company focused on cannabis based medical drugs, and their recent R&D breakthrough for those suffering from IBD & Crohn's Disease.
In this article: VBIO Also: LBIO, INO, GWPH
Read
Cannabis Industry Should Benefit From The 21st Century Cures Act
Article By: Jason Napodano
Wednesday, December 14, 2016 1:38 PM EDT
The cannabis industry should benefit greatly from the passing of the Cures Act. The medical benefits of marijuana, or more specifically, cannabinoids, are real.
In this article: VBIO
Read
Vitality Biopharma Taking Cannabinoid Research To The Next Level
Article By: Jason Napodano
Wednesday, November 30, 2016 12:14 PM EDT
The medical marijuana and cannabis industry in the U.S. is booming. Vitality Bio is currently conducting preclinical studies in anticipation of filing IND applications in 2017 for glycosylated cannabinoid products called cannabosides.
In this article: VBIO
Read

Latest Tweets for $VBIO

No tweets yet!

PARTNER HEADLINES

$VBIO

Interview With Vitality Biopharma Inc.
Alpha Stockman 3/24/2017 10:39:50 PM

Any updates on $VBIO?

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:14:03 PM

I picked up some $VBIO but it hasn't done well for me since. But it's a longer-term play. I'm not expecting a quick flip.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Interview With Vitality Biopharma Inc.
Robert T. Brooke 2/22/2017 7:27:09 PM

Thanks for the interview, @[InvestInMJ](user:5801). Happy to answer any readers' questions on #VitalityBiopharma. $VBIO

Interview With Vitality Biopharma Inc.
Alpha Stockman 2/6/2017 9:43:53 PM

I'm in for some $VBIO

Interview With Vitality Biopharma Inc.
Anastasija Janevska 2/3/2017 9:41:57 PM

@[InvestInMJ](user:5801), how can we get a copy of your newsletter once you have more info? Thanks. $VBIO.

Interview With Vitality Biopharma Inc.
Bill Johnson 2/1/2017 6:09:16 AM

Definitely going to take a closer look at $VBIO, thanks.

Interview With Vitality Biopharma Inc.
Anastasija Janevska 1/31/2017 8:52:01 PM

Very impressive InvestInMJ. So would you recommend picking up some shares of $VBIO? Did you purchase it?

Interview With Vitality Biopharma Inc.
Kurt Benson 1/31/2017 5:11:17 PM

This company looks very promising. I have to admit, I haven't heard of #VitalityBiopharma before but will be doing more due diligence on the stock and will consider adding it to my portfolio. $VBIO.

Vitality Biopharma Taking Cannabinoid Research To The Next Level
Bill Johnson 12/1/2016 4:03:10 AM

@[Logical One](user:35635)'s accusations about this stock are very disconcerting! @[Jason Napodano](user:33738), as the author of this piece, do you have anything else to say about $VBIO?

1 to 10 of 10 comments